Condition category
Nutritional, Metabolic, Endocrine
Date applied
04/07/2011
Date assigned
23/12/2011
Last edited
22/08/2016
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Type 2 diabetes develops when the body does not produce enough insulin to maintain a normal blood sugar (glucose) level, or when the insulin that is being produced does not work properly (insulin resistance). If this happens then blood glucose levels can become high because it is unable to use the glucose for energy. Those with type 2 diabetes are at an increased risk of heart disease, stroke, kidney failure and eyesight problems (diabetic retinopathy). Type 2 diabetes is usually associated with obesity and other risk factors include high blood pressure and a family history of the condition. The number of people with type 2 diabetes is increasing dramatically in the UK. Type 2 diabetes used to be a condition of older people, but more and more young people are showing signs of this disease. In order to develop ways of treating diabetes in the young, it is necessary to understand why it develops and how this affects their health. For this study we plan to collect data on lifestyle, ability to exercise, diet, heart and nerve function to help us start to develop better education and treatment goals in young people with type 2 diabetes. This data will help us to develop an understanding of the impact of type 2 diabetes on the lifestyle of young adults.

Who can participate?
To take part you need to be between 18 and 40 years old and diagnosed with type 2 diabetes, or to be in the control group (without type 2 diabetes) you must have a body mass index (BMI) between 18.5-24.9 kg/m2 or over 29.9 km/m2.

What does the study involve?
If you take part you will go to Loughborough University for your first visit. There you will complete health questionnaires about your diet and any physical activity you do and a clinician will ask you some questions about your lifestyle and understanding of type 2 diabetes. Afterwards, you will have your weight, height, waist and hip circumference and blood pressure measured. Next you will cycle on a stationary bike for about 10 minutes to measure your fitness and give a small blood sample before and after cycling. Your heart rate will be measured when you are cycling.
One week later you will go to Glenfield Hospital where images of your heart will be taken during a cardiac magnetic resonance imaging (MRI) scan. You will give a blood sample before the scan and a range of measures will be checked including glucose, insulin, vitamin D, cholesterol, thyroid function and measures of inflammation and immune function. A routine electrocardiogram (heart trace) will also be performed before the MRI scan.
Between the two study visits your physical activity will be measured using a meter similar to a pedometer (called an accelerometer) which is worn on your waist band. It records how much activity you do in a day. You will wear this meter for 1 week, during waking hours.

What are the possible benefits and risks of participating?
This study itself will not be of direct benefit to you but it will lead to further research in this area which could improve the treatment of people with type 2 diabetes. However, by taking part you will be provided with information about how much physical activity you perform and how your heart functions using the latest technology. The results of this study will be used to improve future assessment and care for patients like you and it is likely you will have a better understanding of why you may have developed Type 2 diabetes (if you are a patient) and the effects of this disease on your heart function.
Taking part involves minimal risk for you, just the inconvenience of taking the time to participate in the study. MRI scanning and exercise tests are very safe and both will be monitored by a doctor from the research team.
The tests in the study are not designed for clinical diagnosis, but in the unlikely event that we may find an abnormality this will be discussed directly with you. With your permission, we will pass this information to your GP and any relevant specialist(s) with the aim of organising prompt and appropriate investigation and treatment.

Where is the study run from?
The first visit of the study takes place at Loughborough University in the Exercise Laboratory in the Clyde Williams building. The second visit takes place at the Radiology Department at Glenfield Hospital, Leicester.

When is the study starting and how long is it expected to run for?
Patients and control participants have started enrolling for the study from October 2009 until May 2011.

Who is funding the study?
The Medical Research Council.

Who is the main contact?
Dr Emma Wilmot
Emma.Wilmot@uhl-tr.nhs.uk

Trial website

Contact information

Type

Scientific

Primary contact

Dr Emma Wilmot

ORCID ID

Contact details

Leicester Royal Infirmary
Infirmary Square
Leicester
LE1 5WW
United Kingdom
-
emma.wilmot@uhl-tr.nhs.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

7506

Study information

Scientific title

Early detection of cardiovascular dysfunction and health behaviours in the young with type 2 diabetes: an observational study

Acronym

Study hypothesis

To characterise health behaviours and beliefs and document early cardiovascular dysfunction in the young with type 2 diabetes (T2DM). This is a pilot study to extensively phenotype young people with T2DM. Biochemical markers and objective measures of metabolic and vascular dysfunction and measures of health behaviours and beliefs will be assessed. These data will be used to design an appropriate lifestyle intervention and early risk reduction and structured education programme.

Ethics approval

North Nottinghamshire Research Ethics Committee,13 March 2009, ref: 09/H0407/9

Study design

Non-randomised observational study

Primary study design

Observational

Secondary study design

Non randomised controlled trial

Trial setting

Hospitals

Trial type

Diagnostic

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Type 2 diabetes

Intervention

Description: 20 young people (aged 18 – 30) with T2DM, 10 age matched controls and 10 age and BMI matched controls.

The study involves two visits. Visit one data on anthropometric, demographic and psychological variables are collected. Participants complete a VO2 max test and undergo pre and post exercise blood sampling.

Visit two involves fasting blood samples and a detailed cardiac magnetic resonance imaging (MRI) with stress perfusion testing and an echocardiogram. Between visits participants wear an accelerometer for 1 week which allows for the objective measurement of physical activity.

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

1. Lifestyle change
2. Depression
3. Illness beliefs
4. Weight
5. Cardiovascular diseases (CVD) risk

Secondary outcome measures

1. Cardiac MRI and echocardiogram data
2. Maximal oxygen consumption (VO2) max
3. Physical activity measured by accelerometer
4. Inflammatory biomarkers: IL-6, TNF alpha, IL6 receptor, hsCRP
5. Biochemical outcomes: HbA1c, glucose, insulin, c-peptide, vitamin D, U&E, LFTs, TFTs
6. Psychological variables measured through questionnaire and semi-structured interviews
7. Anthropometric variables: Body mass index (BMI), waist circumference, blood pressure

Overall trial start date

05/10/2009

Overall trial end date

29/07/2011

Reason abandoned

Eligibility

Participant inclusion criteria

1. Aged 18-30
2. Type 2 diabetes
3. Either male or female

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

UK Sample Size: 40

Participant exclusion criteria

1. Estimated glomerular filtartion rate (eGFR) < 60mls/min
2. Asthma
3. Body weight more than or equal to 150kg
4. Contraindication to magnetic resonance imaging (MRI)

Recruitment start date

05/10/2009

Recruitment end date

29/07/2011

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Leicester Royal Infirmary
Leicester
LE1 5WW
United Kingdom

Sponsor information

Organisation

University Hospitals of Leicester NHS Trust (UK)

Sponsor details

Diabetes Research
Leicester Royal Infirmary
Infirmary Square
Leicester
LE1 5WW
United Kingdom

Sponsor type

Hospital/treatment centre

Website

http://www.leicestershospitals.nhs.uk/

Funders

Funder type

Research council

Funder name

Medical Research Council (MRC) (UK) ref: 77952

Alternative name(s)

MRC

Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2014 results: http://www.ncbi.nlm.nih.gov/pubmed/24606573

Publication citations

Additional files

Editorial Notes

22/08/2016: Publication reference added